Neil Dahiya

**Headline:** Urban Genomic Research Links Genetic Profiling to Increased Survival Rates **Content:** Over a span of seven years (2015-2021), Metropolis Healthcare embarked on a pivotal research endeavor to investigate the clinicopathological characteristics and molecular transformations in patients with lung cancer. […]

Emoneeds, a pioneering digital platform in mental health care, has revealed plans to significantly grow its workforce. This move is part of the company’s strategy to enhance its services and provide superior mental health care throughout India. Currently, Emoneeds has

A 57-year-old woman, experiencing intense headaches and mobility issues, has made a substantial recovery after a sophisticated neurosurgical procedure at Sahyadri Super Speciality Hospital, Hadapsar. Having previously consulted several hospitals in the vicinity, she was eventually identified with multiple meningiomas

A recent study by LoEstro Advisors in cooperation with leading healthcare consultant Medium Healthcare, titled “Hospitals for Bharat,” has highlighted significant challenges alongside potential opportunities within India’s healthcare delivery. The report sheds light on the troubling situation: while small and

In a major social drive, the Anil Agarwal Foundation (AAF), the philanthropic division of Vedanta Limited, has committed Rs. 437 crore for its initiatives in the fiscal year 2023-24, aiming to enrich the lives of over 1.73 crore people throughout

The All India Drugs Control Officers’ Confederation (AIDCOC) is set to commemorate its 30th anniversary on November 23, 2024. This landmark occasion celebrates three decades of commitment to drug regulation and the safeguarding of public health and will be held

Nurix Therapeutics, a clinical-stage company known for developing drugs that adjust protein levels to target cancer and inflammatory diseases, has announced a significant milestone. The European Medicines Agency (EMA) has designated its drug, NX-5948, for PRIME (PRIority MEdicines) status. This

The World Health Organization (WHO) has unveiled a set of guidelines aimed at ensuring ethical collection, access, usage, and sharing of human genomic data. Developed with input from the WHO Technical Advisory Group on Genomics (TAG-G) and a panel of

**Kura Oncology, Inc., a biopharmaceutical company specializing in clinical-stage drug development, and Kyowa Kirin Co., Ltd., an international specialty pharmaceutical firm, have announced a global partnership.** The agreement focuses on developing and marketing ziftomenib, Kura’s selective oral menin inhibitor, currently

Maypharm’s distinctive strategy targets high-entry-barrier markets with bespoke business models, setting itself apart within a competitive and highly regulated environment. The company emphasizes niche, region-specific products like Metamizole, alongside complex injectables, pioneering generics, and advanced drug delivery systems, to cultivate